Today, a panel of the Federal Circuit (Judges Moore, O’Malley, and Hughes) heard oral argument in Genentech v. Amgen. The case is on appeal from the District of Delaware, where the court denied Genentech’s motion for preliminary injunction to halt sales of Amgen’s bevacizumab biosimilar product, MVASI. As we have…
